The number of chronic kidney disease patients in Japan is said to be 13.3 million, and the number of patients receiving renal replacement therapy is increasing year by year. The use of renal replacement therapy can be expected to significantly prolong the prognosis of life. However, in recent years, the necessity of comprehensive renal replacement therapy has been re-recognized with the aging of chronic kidney disease patients and the increase of dementia patients. The treatment of total pain in patients with chronic kidney disease is performed first by relieving physical distress, such as by reviewing dialysis conditions. However, in cases where psychological distress such as anxiety, depression, or insomnia remains, psychiatrists are required. In the case of chronic kidney disease, attention must be paid to the use of psychotropic drugs, mainly for renal excretion type drugs. From the viewpoint of advanced care planning, it is expected that the number of cases in which psychiatrists are asked for opinions regarding the consent ability of patients in the field of decision support for renal replacement therapy will increase more and more in the future.
View full abstract